This live session took place on September 18, 2018 in partnership with Bloomberg Intelligence
The world-wide neurostimulation market is catching the eye of many within the medtech, pharmaceutical and investing industries. This is because of the accelerated growth in the U.S. and European markets and the over 100 million potential patients with chronic pain, Parkinson’s disease, epilepsy and many more indications that can be treated with neurostimulators. Bloomberg Intelligence and Decision Resources Group co-hosted a webinar discussion on the current and future breakdown of the overall neurostimulation market and its potential to impact the aforementioned industries.
Our analysts discussed:
Please complete the form below view the webinar recording